A Case of Organizing Pneumonia Associated with Rituximab / Journal of the Korean Cancer Association, 대한암학회지
Cancer Research and Treatment
;
: 88-91, 2007.
Artículo
en Inglés
| WPRIM
| ID: wpr-195935
ABSTRACT
Rituximab is a human/murine chimeric anti-CD20 mono- clonal antibody used to treat CD20-positive B-cell non- Hodgkin's lymphoma (NHL). Although most of the adverse effects associated with rituximab are usually reversible and temporary infusion-related reactions, including fever, chills, flushing and skin reactions, there are several reports of pulmonary events after long-term administration of rituximab. We present a case of asymp-tomatic nodular organizing pneumonia occurring during rituximab-based chemotherapy in a patient with non- Hodgkin's lymphoma.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Asunto principal:
Neumonía
/
Piel
/
Linfoma no Hodgkin
/
Enfermedad de Hodgkin
/
Linfocitos B
/
Escalofríos
/
Quimioterapia
/
Fiebre
/
Rituximab
/
Rubor
Límite:
Humanos
Idioma:
Inglés
Revista:
Cancer Research and Treatment
Año:
2007
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS